DocuSign's specializes in providing cloud-based solutions for managing and signing agreements and contracts.
Shares of DocuSign surged as much as 24% on Friday after the company posted revenue that beat Wall Street expectations. The company reported total revenue of $235.6 million in the second quarter, up from 41% during the same period last year. Wedbush analyst Daniel Ives upgraded the stock to"outperform" from"neutral" and raised his price target to $65 from $48. Ives cited DocuSign's growing revenues and total billings as the drivers for the upgrade.
Shares of DocuSign surged as much as 24% on Friday after the company posted revenue that beat Wall Street expectations. The company reported total revenue of $235.6 million in the second quarter, up from 41% during the same period last year. Wedbush analyst Daniel Ives upgraded the stock to"outperform" from"neutral" and raised his price target to $65 from $48. Ives cited DocuSign's growing revenues and total billings as the drivers for the upgrade.
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
I'm 24, Make $56,000 A Year—& My Student Loans Are Almost $1,000 A Month8:40 a.m. — I read the paper quickly, but I'm running late (by my standards, which means I'm five minutes early) to Pilates. I grab a granola bar and rush out the door.
Leer más »
24 Ariana Grande Hairstyles That Will Make You Want to Rock a High PonytailI need some hair extensions ASAP.
Leer más »
Stocks making the biggest moves after hours: DocuSign, Lululemon and moreSee which stocks are posting big moves after the bell.
Leer más »
DocuSign rises 19% on revenue beat and strong guidanceThe enterprise cloud company beat analyst expectations on revenue and provided strong guidance for the next quarter and full fiscal year.
Leer más »
Australia follows familiar, grim path to an opioid crisisBLACK RIVER, Australia (AP) — Half a world away from the opioid epidemic ravaging the United States, Australia is facing a crisis of its own, with skyrocketing rates of opioid prescriptions and...
Leer más »